ReviewCurrent opinion in neurology2025
Epilepsy in low- to middle-income countries.
Review in Current opinion in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Barriers to care in epilepsy surgery clinics in Latin America: a systematic review of social-economic impact.Neurosurgical review · 2026Pooled it
- Caregiver burden and associated factors among primary caregivers of children with epilepsy in southwestern Uganda.Epilepsy & behavior reports · 2026Article
- Global trends in epilepsy and the Chinese experience: Epidemiological transitions, underlying mechanisms, and integrated strategies (1990-2021).Neuroprotection (Chichester, England) · 2026Review
- Artificial Intelligence for Improving the Management of People With Epilepsy in Low-and-Middle Income Countries.European journal of neurology · 2026Review
- Data-Driven Clinical Phenotyping of Adult Epilepsy Using Latent Class Analysis: A Regional Cohort Study from Southern Kazakhstan.Journal of personalized medicine · 2026Article
- Referral to an Apex Tertiary Center in Pediatric Epilepsy: A Prospective Cost-of-Illness Study.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026Article
- Medication Adherence and Quality of Life in Epilepsy: The Potential Role of Seizure Severity in the Association Between Them.Journal of clinical medicine · 2026Article
- Impact of an mhGAP-based epilepsy training program on primary healthcare providers in Palestine: a quasi-experimental study in an under-resourced setting.BMC primary care · 2026Article
- Forecasting the prevalence of epilepsy in low- and middle-income countries to 2050 using a hybrid deep neural network-transformer modeling framework: insights from the Global Burden of Disease Study 2023.Military Medical Research · 2026Article
- Breaking the resistance: a narrative review of the evolution from traditional drugs to precision therapies in epilepsy.Annals of medicine and surgery (2012) · 2026Review
- Non-adherence to epileptic medications among adult patients in south west Shewa zone hospitals of central Ethiopia.Scientific reports · 2025Article
- Remote follow-up for pediatric epilepsy: effective care with equity-focused oversight.Frontiers in public health · 2025Review
- Article
- Portable neuroimaging and AI: democratizing brain diagnostics.Frontiers in neurologyArticle
- Knowledge, awareness, and attitudes toward epilepsy in Palestine: a cross-sectional study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewEpilepsy disproportionately affects those in low- and middle-income countries (LMICs) where diagnostic and treatment gaps persist.We highlight key recent developments and showcase practical opportunities to improve epilepsy care in resource limited settings. RECENT
findingsIn LMICs, cultural, socioeconomic and infrastructural factors drive the epilepsy treatment gap. Robust implementation of the WHO Intersectoral Global Action Plan (WHO IGAP) and Mental Health Gap Action Program (mhGAP), for example, will reduce the epilepsy education gap. Engaging traditional healers and other key community leaders should lessen stigma. The Epilepsy Diagnostic Companion, a culture specific tool that helps identify convulsive seizures, can expedite epilepsy diagnosis at primary care level. Novel, robust 3-D printable EEG headsets prototypes that can be deployed in remote rural communities have been piloted with encouraging results. Levetiracetam has been added to the WHO Essential Medicines List (EML), paving way to safer, less teratogenic antiseizure medications (ASMs). Epilepsy surgery programs in carefully selected patients potentially offer cheap, effective and potentially curative treatments, including in LMICs. SUMMARY: Apps, EEG prototypes, better access to ASMs and implementation of WHO iGAP offer current, tangible opportunities to improve epilepsy care in LMICs. Bidirectional learning must be facilitated to also help hard to reach communities in high-income settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.